ONCO Stock Analysis: Buy, Sell, or Hold?
ONCO - Onconetix, Inc. Common Stock
$0.94
-0.05 (-4.62%)
▼
5d:
-1.67%
30d:
-0.78%
90d:
-22.99%
BUY
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When ONCO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
6 traders called ONCO this week
89% bullish • 1 bearish
89% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ONCO shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: ONCO shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ONCO is currently trading at $0.94, which is considered slightly high relative to its 30-day fair value range of $0.98 to $1.11.
Technical Outlook: Technically, ONCO is in a downtrend. The price is currently testing key support at $0.92. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+858.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ONCO is in a downtrend. The price is currently testing key support at $0.92. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+858.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.98 -
$1.11
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.6%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.6%)
- BULLISH: Trading 858.0% below Wall St target ($9.00)
Trading Range Analysis
30-Day Trading Range
$0.98 -
$1.11
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.92
Resistance Level
$1.31
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$9.00
(+858.0%)
Revenue Growth (YoY)
-78.9%
Share & Embed Analysis
Last updated: July 11, 2026 3:00 AM ET
Data refreshes hourly during market hours. Next update: 4:00 AM
Data refreshes hourly during market hours. Next update: 4:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ONCO showing a specific setup today?
Insider Activity (6 Months)
3
Buys
3
Sells
0
Net
NEUTRAL
Recent Transactions
Financial Lp Hrt
SELL
49710 shares
2026-04-21
Financial Lp Hrt
SELL
94462 shares
2026-04-20
Financial Lp Hrt
BUY
34636 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1051 | 55 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 52 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 60 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 53 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 45 HOLD |
